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Abstract
Background: Technological progress has enabled the provision of personalised feedback across multiple
dimensions of physical activity that are important for health. Whether this multidimensional approach supports
physical activity behaviour change has not yet been examined. Our objective was to examine the effectiveness of a
novel digital system and app that provided multidimensional physical activity feedback combined with health
trainer support in primary care patients identified as at risk of chronic disease.
Methods: MIPACT was a parallel-group, randomised controlled trial that recruited patients at medium (≥10 and <
20%) or high (≥20%) risk of cardiovascular disease and/or type II diabetes from six primary care practices in the
United Kingdom. Intervention group participants (n = 120) received personal multidimensional physical activity
feedback using a customised digital system and web-app for 3 months plus five health trainer-led sessions. All
participants received standardised information regarding physical activity. Control group participants (n = 84)
received no further intervention. The primary outcome was device-based assessment of physical activity at 12
months.
Results: Mean intervention effects were: moderate-vigorous physical activity: -1.1 (95% CI, − 17.9 to 15.7) min/day;
moderate-vigorous physical activity in ≥10-min bouts: 0.2 (− 14.2 to 14.6) min/day; Physical Activity Level (PAL): 0.00
(− 0.036 to 0.054); vigorous physical activity: 1.8 (− 0.8 to 4.2) min/day; and sedentary time: 10 (− 19.3 to 39.3) min/
day. For all of these outcomes, the results showed that the groups were practically equivalent and statistically ruled
out meaningful positive or negative effects (>minimum clinically important difference, MCID). However, there was
profound physical activity multidimensionality, and only a small proportion (5%) of patients had consistently low
physical activity across all dimensions.
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Conclusion: In patients at risk of cardiovascular disease and/or type II diabetes, MIPACT did not increase mean
physical activity. Using a sophisticated multidimensional digital approach revealed enormous heterogeneity in
baseline physical activity in primary care patients, and practitioners may need to screen for low physical activity
across dimensions rather than rely on disease-risk algorithms that are heavily influenced by age.
Trial registration: This trial is registered with the ISRCTN registry (ISRCTN18008011; registration date 31 July 2013).
Keywords: Physical activity, Technology, Primary care, Cardiovascular disease, Diabetes, Lifestyle intervention
Introduction
Low physical activity is a major public health problem
and an important independent risk factor for chronic
diseases such as cardiovascular disease (CVD) and
type II diabetes [1]. Primary care provides a potential
route to change physical activity in patients at risk of
chronic disease. In the United Kingdom, National
Health Service (NHS) Health Checks screen for at-
risk adults and include brief advice on increasing
physical activity [2]. However, past attempts to
change physical activity in primary care have had only
limited success [3]. Identifying strategies to increase
physical activity in high-risk individuals in primary
care settings remains a priority.
New digital technologies have the potential to trans-
form the way in which physical activity is integrated
into healthcare and used to target individuals at risk
of long-term conditions [4]. Technology-assisted ap-
proaches can support more sophisticated, flexible and
personalised delivery models [4–6] and can integrate
key behavioural strategies associated with greater
intervention effectiveness for modifying physical activ-
ity, including self-monitoring and feedback on behav-
iour [7, 8]. Indeed, a recent systematic review and
meta-analysis called for future interventions aiming to
promote longer term physical activity to specifically
consider using personalised feedback as a behaviour
change technique in order to enhance intervention ef-
fects [9].
Emerging evidence suggests that the health benefits
of physical activity can be achieved in a variety of
ways, and multiple dimensions (aspects) of physical
activity are important for health promotion and dis-
ease prevention [10, 11]. Our past research shows
that many people misjudge their physical activity sta-
tus because they do not have access to accurate per-
sonalised information [12, 13]. We developed
technology to capture multiple dimensions of physical
activity and thus improve the depth and quality of
feedback provided to individuals [14]. In addition to offer-
ing a more complete and integrated view of personal phys-
ical activity, a multidimensional approach potentially
offers more behavioural options that can be tailored to an
individual’s needs and preferences [10].
In the Multidimensional Individualised Physical
ACTivity (MIPACT) study, we conducted a rando-
mised controlled trial to examine whether
technology-enabled feedback about personalised
multidimensional physical activity combined with
support from health trainers increased physical activ-
ity in patients at risk of cardiovascular disease and/
or type II diabetes, recruited from primary care. This
trial was funded by the National Prevention Research
Initiative (NPRI) – a partnership of research coun-
cils, government, and medical charities in the United
Kingdom prioritising disease prevention. Prior quali-
tative feedback from at-risk patients was used to in-
form the design of physical activity visualisations,
the development of an accompanying web-based app
for communicating novel multidimensional physical
activity feedback and the inclusion of health trainer
support in the present trial [12, 13].
Methods
Study design
The MIPACT study was a parallel group, single blind,
randomised clinical trial enrolling 204 patients identi-
fied as being at risk of cardiovascular disease and/or
type II diabetes, and consisted of a 3-month interven-
tion period with follow-up at 3 and 12 months (pri-
mary timepoint). Ethics approval was obtained from
the National Health Service (NHS) South West Re-
search Ethics Committee (13/SW/0179). All patients
provided written informed consent. The trial was reg-
istered on the ISRCTN registry on 31 July 2013
(ISRCTN18008011). A full protocol detailing trial
methods has been published previously [15]. Data
were collected and reported according to CONSORT
guidelines (Additional file 1).
Participants
Patients were recruited from six general medical
practices in the South West of the United Kingdom
between May 2014 and June 2015. Potential partici-
pants were approached via a letter from their Gen-
eral Practitioner. Eligible patients were men and
women aged 40–70 years treated in primary care and
with medium (≥10 and < 20%) or high (≥20%) risk of
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cardiovascular disease and/or type II diabetes. Risk
scores were based on QRISK and QDiabetes predic-
tion algorithms [16, 17] using clinical data. As our
focus was on prevention, patients with existing cor-
onary heart disease, heart failure, peripheral arterial
disease, stroke, chronic kidney disease and diabetes
mellitus were excluded. Individuals unable to in-
crease physical activity or highly physically active in-
dividuals (a PAL – the ratio of total energy
expenditure to basal metabolic rate – greater than
2.0) were also excluded.
Randomisation and allocation
Eligible patients were allocated to one of two groups
using an unequal allocation ratio (intervention: con-
trol) of 2:1, primarily to increase our experience with
and amount of information on the new intervention
with respect to delivery, receipt, and enaction [18].
Participants were allocated remotely by the trial stat-
istician via concealed minimisation [19], providing
balance across the trial arms for sex (male/female),
general practice (1–5), risk (both cardiovascular dis-
ease and type II diabetes; medium/high) and baseline
PAL (< 1.75 or > 1.75). Individual patients were the
unit of randomisation, but there was no threat of
contamination within a practice given that the inter-
vention was personalised. Researchers assessing the
primary outcomes were blinded to the allocation of
participants.
Intervention
The MIPACT intervention was a complex ‘treatment
package’ developed in line with Medical Research
Council guidelines for the development of complex
interventions [20], and has been described previously
[15] (see Additional file 2 for TIDieR checklist for
intervention description). In brief, intervention con-
tent was developed by the project team and was in-
formed by prior research on multidimensional
physical activity and feedback in at-risk patient popu-
lations in primary care [12, 14]. We showed that at-
risk groups were confident in using the technology
and found feedback to be understandable and motiv-
ating. However, consistent with other qualitative work
in at-risk patients [21] it was identified that health
trainer support would be useful for sustaining motiv-
ation and engagement.
Behaviour change techniques common with suc-
cessful lifestyle interventions were targeted by both
the web-based app and the trainers [7]. The most
prominent behavioural strategies in the web-based
app (corresponding to an established taxonomy)
[22], included feedback on behaviour (2.2), self-
monitoring of physical activity behaviour (2.3),
setting and reviewing goals in the context of target
dimensions (1.1 & 1.5) and visualising the discrep-
ancy between one’s behaviour and the health target
(1.6). Health trainers were able to tailor the content
of their discussions but were encouraged to discuss
action planning/implementation intentions of phys-
ical activity (1.4), the health consequences of phys-
ical activity (5.1), instruction on how to perform
specific physical activities (4.1) and building self-
belief (15.1 & 15.3).
Recent research has shown that the use of multiple
co-acting behaviour change techniques are required
to promote motivationally adaptive healthcare
environments [23, 24]. Thus, and in addition to the
use of behaviour change techniques, a number of
theoretically-informed intervention components
based on self-determination theory were applied [25].
Within self-determination theory, healthcare ex-
changes that are supportive of an individual’s basic
psychological needs for autonomy (i.e., need to feel
that one’s behaviours are self-endorsed and vol-
itional), competence (i.e., the need to feel effective
and experience mastery in one's actions) and related-
ness (i.e., the need to feel connected and cared for)
are held to facilitate greater autonomous motivation
and subsequently improved performance and in-
creased maintenance of a given behaviour [26, 27].
The MiPACT intervention sought to support auton-
omy through the provision of behavioural choice in-
herent in the multidimensional physical activity
profiles and via the trainer discussions wherein the
users’ perspective of their current behaviour was ex-
plored, the use of a meaningful rationale, and en-
couragement to explore new enjoyable activities.
Competence was targeted via the clear, visual feed-
back and self-monitoring of behaviour, and through
the trainer supporting individuals in overcoming bar-
riers to change, setting realistic goals and action
plans, and by means of the provision of constructive
verbal feedback and encouragement when talking
through the visual data. Trainers were also encour-
aged to show empathy, acknowledge participant feel-
ings, and build a collaborative relationship to
support the need for relatedness.
All participants (including the control group)
attended an initial 20-min meeting with a health
trainer and received standardised information (in-
cluding print-based materials and links to internet-
based resources) regarding type II diabetes and car-
diovascular disease, the potential benefits of phys-
ical activity on ‘risk’ reduction, current physical
activity guidelines, ideas about getting more physic-
ally active, and included signposting to local
opportunities.
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Content was consistent with other print and
internet-based resources such as NHS Choices (www.
nhs.uk/livewell). Hence, the trial assessed effectiveness
over-and-above existing ‘usual care’ alternatives. Con-
trol group participants received no further study
intervention.
The MIPACT intervention involved access to a so-
phisticated wearable activity monitor and a custo-
mised web-based app for 3 months. The physical
activity monitor was a multisensor device that esti-
mates energy expenditure (BodyMedia Core). Partici-
pants were encouraged to wear activity monitors as
much as possible and to regularly access the platform
during the intervention. Personalised physical activity
feedback could be accessed by participants using the
web-based app at any point over a given 24-h period.
Participants were also offered a further four (20–30
min) in-person health trainer sessions at approxi-
mately 2, 4, 8 and 12 weeks. Health trainers included
5 registered (e.g. dieticians) and non-registered
healthcare professionals (e.g. health trainers) recruited
from the local community with experience as physical
activity or lifestyle advisors, in order to make the
study as pragmatic and generalisable as possible to
routine healthcare practice. Health trainers were pro-
vided written materials and 2-days of intervention de-
livery training; focusing on using an autonomy
supportive style [15].
We included a range of strategies outlined by the
National Institute of Health Behavior Change Consor-
tium to reinforce intervention fidelity [28]. We (1) de-
veloped and implemented standardised training of
intervention providers (2) trained more MIPACT
trainers than needed to protect against dropout or ill-
ness (3) recorded a selection of consultation meetings
for a sample of sessions per intervention provider (4)
implemented fidelity checklists, and (5) provided for-
mative feedback to health trainers. Engagement of
participants with the use of activity monitors and the
web-based app was assessed by the number of moni-
tor wear days across the intervention, the number of
days that monitor data were uploaded to the web-
based app, and the total number of trainer sessions
attended.
Activity monitor data were used to generate per-
sonal visual feedback and to enable remote self-
monitoring through the app. Multidimensional phys-
ical activity data were depicted in a simple wheel and
bar chart format using traffic light colour-coding as
an index of attainment [15]. Each participant’s profile
captured five different dimensions: (1) total energy ex-
penditure, (2) minutes engaged in moderate-to-
vigorous physical activity (MVPA) (3) time engaged in
MVPA in ≥10-min bouts (4) time engaged in vigorous
physical activity in ≥10-min bouts, and (5) sedentary
time as a proportion of the waking day. The app in-
cluded feedback on time spent and energy expended
at different physical activity intensities (sedentary,
light, moderate, vigorous and very vigorous),
expressed in metabolic equivalents (METs). In order
to convert energy expenditure to METs, we used age-
specific equations for Basal Energy Expenditure [29].
This was used to determine the amount of time en-
gaged in sedentary behaviour (< 1.8 METs), light in-
tensity physical activity (1.8–3 METs), MVPA (≥3
METs) and vigorous intensity physical activity (≥6
METs). These data were presented as 24-h line
graphs and daily/weekly summary charts using a ‘heat’
colour palette [15]. The app also offered reviewing
and planning components, and functionality for tag-
ging different behaviours as part of the self-
monitoring process [15].
The aim of the first health trainer session was to
explain the multidimensional nature of physical ac-
tivity and physical activity intensity thresholds, dis-
cuss which personal behaviours contributed to each
dimension and discuss acceptable and available op-
tions to increase daily physical activity. Participants
were encouraged to engage in new and enjoyable ac-
tivities. A focus of the second session was to review
progress and to discuss aspects that participants
would consider changing and to set a SMART (Spe-
cific, Measurable, Attainable, Realistic, and Time-
bound) goal. Subsequent sessions involved reviewing
physical activity behaviour(s) and supporting efforts
to be more active and included continued support in
refining goals and action plans. The process was led
by the participant (i.e. “self-regulated”) and was
highly individualised.
Outcome measures
All participants were assessed at baseline and
followed up at 3 and 12 months within clinic. The
primary outcome was device-based assessment of
physical activity at 12 months. The device used to
collect physical activity energy expenditure was a
research-grade multisensor instrument worn on the
upper arm (BodyMedia Core, BodyMedia Inc., Pitts-
burgh, PA) that has been used in research studies
and has excellent reported accuracy [30, 31]. Under-
lying raw minute-by-minute estimates of energy ex-
penditure were extracted in order to undertake the
necessary data processing to then extract the specific
physical activity metrics needed for our analysis
(SenseWear® Pro 8.0, algorithm v5.2). Weekly phys-
ical activity energy expenditure records were
exported to Excel for processing. Data were consid-
ered valid if the participant wore the device for ≥6
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days in which 80% or more data were captured
within a given 24-h period. Missing data were
assigned estimated energy expenditure equivalent to
basal metabolic rate (Schofield et al., 1985). Physical
Activity Level (PAL) was determined as the product
of Total Energy Expenditure/Basal Metabolic Rate.
Multiple other key physical activity dimensions were
calculated, including: overall physical activity energy
expenditure (expressed as PAL); accumulated mi-
nutes engaged in MVPA (≥3 METs) and in ≥10-min
bouts; time engaged in vigorous intensity physical
activity (≥6 METs) in ≥10-min bouts, and sedentary
time (< 1.8 METs), where one MET represents rest-
ing metabolic rate.
As per study protocol [15], to explore if any change
in physical activity is meaningful in terms of health
risk, we included secondary outcomes for the change
between baseline and 12 months in body mass, body
mass index, waist circumference, fat mass, systolic
and diastolic blood pressure, glucose control (glucose
and insulin), lipids (total cholesterol, high-density and
low-density lipoprotein cholesterol, triglycerides), and
C-reactive protein. Anthropometric measurements and
blood samples were taken by a research nurse in
clinic, while body composition was estimated using
dual energy X-ray absorptiometry. Risk scores were
based on QRISK and QDiabetes prediction algorithms
[16, 17] using clinical data. Health status was assessed
using the Euroqol 5-D visual analogue scale (EQ. 5-
D) [32]. A full process evaluation for MIPACT, in-
cluding self-reported psychosocial variables, will be
published separately.
Statistical analysis
For a targeted difference in PAL of 0.07 and an SD
of 0.18, [15] 2-sided P = 0.05, 90% power, an assumed
correlation between baseline and follow-up of r = 0.7,
and a 2:1 allocation ratio, the required sample size
(allowing for 25% attrition) was 144 in the interven-
tion group and 72 in the control (ANCOVA model)
[33]. In an as-randomised analysis, we estimated the
mean difference in 12-month outcome between arms.
We applied a linear mixed model with restricted max-
imum likelihood and an identity covariance structure.
All minimization factors and the baseline value of the
outcome were included as fixed effects, plus a ran-
dom slope for group allowing different response vari-
ances. The same analysis was applied to all physical
activity dimensions, with no adjustment for multipli-
city [34].
Our definition of the minimum clinically import-
ant difference (MCID) for MVPA was based on a
prospective study of adults at risk of type 2 diabetes
mellitus, wherefrom we can derive that the mean
increase in MVPA time per day associated with a
clinical meaningful 10% relative risk reduction in
all-cause mortality was approximately 20% [35]. In
the current study, 20% of the baseline mean
equated to around 30 min/day and 20 min/day, re-
spectively, for MVPA and for MVPA in 10-min
bouts. The MCID for vigorous physical activity in
10-min bouts was set at half of that for MVPA (10
min/day), as there is no robust clinical anchor. The
MCID for PAL was defined as 0.07, as detailed in
our protocol paper [15], and for sedentary time as
1 h per day, as there is no robust clinical anchor in-
dependent of MVPA.
Model specification was evaluated by visual inspec-
tion of residuals plots. Mean intervention effects are
presented with 2-sided 95% confidence intervals,
providing a range of effect sizes compatible with the
data and model. A zero effect ± the MCID defines a
region of practical equivalence. The disposition of
the confidence interval to this region may be used to
statistically rule out substantial beneficial (favouring
intervention) or harmful (favouring control) effects,
equivalent to two 1-sided tests each at the 0.025
level [36]. In short, if the entire confidence interval
lies within the region of zero ± the MCID then the
groups may be considered practically equivalent for
that outcome. The same analyses were repeated for
the 3-month physical activity outcomes and for the
health-related outcomes at 3 and 12 months, and are
presented for description only.
With missing data on the dependent variable only,
maximum likelihood reduces to a complete case ana-
lysis under a plausible missing at random assumption,
and therefore cases with missing outcome data (c.
10%) were deleted. Finally, in our trial protocol we
stated that we would explore treatment effect hetero-
geneity. However, when the mean intervention effect
is close to zero, the plausibility of the implicit as-
sumption that a proportion of participants would get
substantially worse with the intervention is question-
able. Therefore, we omitted the planned analysis of
intervention response heterogeneity. All analyses were
performed using Stata software (StataCorp, 2017.
Stata Statistical Software: Release 15, College Station,
TX, USA: StataCorp LP).
Patient and public involvement
The public were involved in this study in several
ways. Draft graphics and visualisations for presenting
multidimensional physical activity data (initially devel-
oped alongside designers) were refined based upon
feedback from in-depth qualitative interviews in at-
risk patients (n = 29) and healthcare practitioners (n =
15) from two regions in the United Kingdom (Bath
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and North East Somerset and Wiltshire). Overall, pa-
tients preferred simple messages rather than more
complex or abstract visualisations. Also, while
technology-enabled physical activity feedback was
found to be informative, understandable and motivat-
ing, it was the view of patients and practitioners that
supplementary in-person guidance may further sup-
port behaviour change and this informed the decision
to include one-to-one health trainer sessions in MIPA
CT [12]. Participants were provided with their results
and were invited to attend focus groups at the end of
the study to learn more about their experiences of
the trial.
Results
Participants
The flow of participants from recruitment through to
final assessment at 12 months is shown in Fig. 1. Partici-
pant characteristics were similar between groups at base-
line (Table 1).
Effect of the intervention on physical activity outcomes
Adjusted means for device-measured physical activity at
12 months (primary endpoint) and 3months are pre-
sented in Table 2. For the primary timepoint at 12
months, the point estimates and lower and upper confi-
dence limits for the intervention effect (vs. control) for
Fig. 1 Flow of participants through the MIPACT study. MIPACT, Multidimensional Individualized Physical ACTivity
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Table 1 Characteristics of study participantsa, b
Variable Total (n = 204) Control (n = 70) Intervention (n = 134)
Age (years) 64 (6) 63 (6) 64 (6)
Male sex 131 (64) 45 (64) 86 (64)
Ethnicity: White British 180 (88) 63 (90) 117 (87)
Marital Status: Married 150 (74) 54 (77) 96 (72)
Employment status
In full or part-time employment 85 (42) 31 (44) 54 (40)
Retired 116 (57) 38 (54) 78 (58)
Area deprivation (IMD score) 7.6 (2.3) 7.7 (2.4) 7.6 (2.3)
Education levels
Up to age 16 or less 63 (31) 18 (26) 45 (34)
Up to age 18 60 (29) 26 (37) 34 (25)
Undergraduate / higher degree 81 (40) 26 (37) 55 (41)
Current smoker 20 (10) 10 (14) 10 (7)
Body mass (kg) 85.2 (14.3) 86.6 (14.1) 84.5 (14.4)
Body mass index (kg/m2) 29.1 (4.4) 29.4 (4.3) 28.9 (4.4)
DEXA
Total body fat (%) 33.4 (8.1) 33.0 (8.5) 33.5 (7.9)
Visceral body fat (cm2) 188 (60) 195 (66) 184 (57)
Fat mass index (kg/m2) 9.7 (3.5) 9.7 (3.6) 9.7 (3.4)
Waist circumference (cm) 100.3 (10.6) 101.2 (10.6) 99.8 (10.5)
Blood pressure (mm Hg)
Systolic 132 (16) 132 (17) 132 (16)
Diastolic 84 (9) 83 (10) 84 (9)
Fasting glucose (mmol/L) 5.1 (0.5) 5.1 (0.5) 5.1 (0.4)
Fasting insulin (mU/L) median (IQR) 54.8 (41.1, 82.2) 58.9 (37.5, 84.1) 51.4 (42.4, 80.4)
HOMA-IR median (IQR) 1.8 (1.3, 2.7) 1.9 (1.2, 2.8)) 1.7 (1.3, 2.6)
Cholesterol (mmol/L)
Total cholesterol 5.8 (1.0) 5.7 (0.9) 5.9 (1.1)
Low-density lipoprotein cholesterol 3.6 (0.9) 3.5 (0.9) 3.7 (1.0)
High-density lipoprotein cholesterol 1.6 (0.4) 1.5 (0.4) 1.6 (0.5)
Triglycerides (mmol/L) 1.4 (0.6) 1.4 (0.7) 1.4 (0.6)
QRISK2: 10-year risk (%) 14.4 (6.3) 13.8 (6.2) 14.8 (6.4)
QDiabetes: 10-year risk (%) 13.5 (9.4) 12.9 (6.9) 13.9 (10.5)
Physical Activity
Sedentary time (min/day) 662 (111) 651 (117) 668 (107)
MVPA (min/day) 149 (57) 157 (60) 146 (56)
MVPA10 (min/day) 96 (47) 103 (52) 92 (44)
Vigorous10 (min/day) median (IQR) 3 (0, 9) 3 (0, 11) 3 (0, 8)
PAL 1.68 (0.16) 1.70 (0.16) 1.67 (0.16)
EQ 5-D VAS 72 (16) 73 (16) 71 (15)
Abbreviations: IMD Index of multiple deprivation, DEXA Dual-energy X-ray absorptiometry, HOMA-IR Homeostatic model assessment – Insulin resistance, PAL
Physical activity level, EQ. 5-D VAS Euroqol 5-D visual analogue scale (health-related quality of life)
a Data are expressed as mean (SD) for continuous data, or N (%) for categorical data. Highly skewed continuous data are presented as median (interquartile
range; IQR)
b N = 186 for DEXA; N = 204 for all other variables
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all dimensions were all trivial in relation to the smallest
effect sizes of interest. For all physical activity dimen-
sions the confidence interval is entirely within the
equivalence region (defined by ± the MCID), indicating
that clinically meaningful mean population effects (as
defined) may be ruled out at the given level of error
control.
Effect of the intervention on health outcomes
Adjusted means for health-related outcomes are shown
in Table 3. These data are provided for descriptive/ex-
ploratory purposes only.
Adherence and adverse events
The dose and coverage of intervention delivery was high.
Among those receiving the MIPACT intervention, the
mean (SD) number of days that activity monitors were
worn across the 3-month intervention period was 72
(25) days. Of these, the number of days regarded as
complete (i.e. ≥80% data for a given 24-h period) was 61
(26) days. On average, participants uploaded data to the
platform on 24 (21) unique days. Of the 134 participants
in the MIPACT intervention group, 121 (90%) attended
≥4 health trainer sessions, and 105 (78%) attended all 5
training sessions. After excluding participants who
dropped out from the study, 85% attended all sessions.
One participant in the control group died due to reasons
deemed unrelated to the study. In total, there were only
10 serious adverse events reported between the interven-
tion and control groups: 7 (5%) of 134 and 3 (4%) of 70,
respectively, and none were deemed related to participa-
tion in the study.
Discussion
In primary care patients at risk of chronic disease, we eval-
uated an intervention comprising personal technology-
enabled feedback on multiple specific dimensions of phys-
ical activity combined with health trainer support. At 12-
months follow-up, the intervention and control groups
were statistically equivalent for all physical activity out-
comes and sedentary time. Between participants there was
considerable variation (or heterogeneity) across the mul-
tiple physical activity dimensions, with only 11 partici-
pants (5%) presenting at baseline with uniformly low
physical activity across all dimensions.
Comparison with other studies
We developed a highly sophisticated system for provid-
ing personalised multidimensional physical activity feed-
back that was informed by patients and practitioners
(MIPACT). This approach did not change physical activ-
ity in at-risk patients recruited from primary care. MIPA
CT confirms that, even using the latest technology as
part of a multicomponent intervention, it is hard to mo-
tivate people at risk of disease to change their physical
activity behaviours. The MIPACT trial represents a first
attempt to leverage technology to improve the depth
and quality of feedback to at-risk patients about the
multiple dimensions of physical activity that can play a
role in disease prevention [10, 11, 14]. To date, physical
activity feedback interventions have typically focused on
just one aspect of physical activity behaviour (e.g. mod-
erate physical activity). In a primary care setting, there is
some evidence that personalised physical activity feed-
back on MVPA [37] or pedometer steps [38] as part of
more intensive lifestyle interventions can lead to in-
creases in physical activity. However, these effects were
modest, and studies targeted patients with existing
chronic disease. No prior randomised trial has examined
the effects of providing personal feedback on multiple
physical activity dimensions as part of a technology-
enabled behavioural intervention in at-risk patient
populations.
Meaning of the study: possible explanations and
implications
There are several potential reasons for the lack of sub-
stantial intervention effects on physical activity
Table 2 Adjusted means for device-based physical activity
outcomes at 3 months and 12monthsa,b (All outcomes in
minutes/day unless stated)
Variables Intervention Control Difference (95% CI)
Sedentary
3 months 651.1 632.5 18.6 (−8.9 to 46.2)
12 months 667.1 657.1 10.0 (−19.3 to 39.3)
MVPA
3months 163.4 174.8 −11.4 (−27.7 to 4.9)
12 months 161.9 163.0 −1.1 (− 17.9 to 15.7)
MVPA10
3 months 112.4 115.1 −2.7 (−17.2 to 11.9)
12 months 107.0 106.8 0.2 (−14.2 to 14.6)
Vigorous10
3 months 9.8 8.1 1.7 (−1.6 to 4.1)c
12 months 8.1 6.3 1.8 (−0.8 to 4.2)c
PAL
3 months 1.72 1.74 −0.02 (− 0.07 to 0.03)
12 months 1.71 1.71 0.00 (−0.036 to 0.054)
Abbreviations MVPA moderate-to-vigorous physical activity, MVPA10 moderate-
to-vigorous physical activity in bouts of at least 10min, Vigorous10 Vigorous
physical activity in bouts of at least 10min, PAL Physical Activity Level (ratio of
total daily energy expenditure to resting metabolic rate)
a Adjusted for all minimization factors and baseline value of the
outcome variable
b N = 183 for sedentary time at 3 months; N = 184 for all other variables at 3
and 12 months
c Confidence interval verified using a bias-corrected and accelerated bootstrap
with 2000 replication
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Table 3 Adjusted means for health-related outcomes at 3 and 12-monthsa
Variable N Intervention Control Difference (90% CI)
Body mass (kg)
3 months 188 84.1 84.3 −0.2 (−1.0 to 0.5)
12 months 186 83.6 84.4 −0.8 (−1.8 to 0.2)
Body mass index (kg/m2)
3 months 188 28.6 28.7 −0.1 (− 0.3 to 0.1)
12 months 186 28.5 28.8 −0.3 (− 0.6 to 0.04)
Waist circumference (cm)
3 months 188 98.3 98.0 0.3 (−0.6 to 1.2)
12 months 186 99.2 99.0 0.2 (−1.2 to 1.5)
Total body fat (%)
3 months 165 32.6 32.5 0.1 (−0.4 to 0.6)
12 months 166 32.4 32.7 −0.3 (− 0.8 to 0.3)
Visceral body fat (cm2)
3 months 165 180.4 183.1 −2.7 (− 8.8 to 3.4)
12 months 166 186.9 193.1 −6.2 (− 13.8 to 1.4)
Fat mass index (kg/m2)
3 months 165 9.3 9.3 0.0 (−0.2 to 0.2)
12 months 166 9.3 9.5 −0.2 (− 0.4 to 0.1)
SBP (mmHg)
3 months 188 129 130 −1 (−5 to 3)
12 months 186 133 133 0 (−3 to 3)
DBP (mmHg)
3 months 188 83 85 −2 (−4 to 0)
12 months 186 82 83 −1 (−3 to 1)
Glucose (mmol/L)
3 months 188 5.1 5.1 0.0 (−0.1 to 0.1)
12 months 183 5.1 5.2 −0.1 (− 0.2 to 0.0)
Insulin (mU/L)b
3 months 183 65.8 68.3 −2.5 (−8.7 to 4.0)
12 months 181 72.2 71.7 0.5 (−7.9 to 9.6)
HOMA-IRb
3 months 183 2.2 2.2 0.0 (−0.3 to 0.2)
12 months 177 2.4 2.4 0.0 (−0.4 to 0.3)
Total cholesterol (mmol/L)
3 months 188 5.6 5.7 −0.1 (− 0.2 to 0.1)
12 months 184 5.7 5.8 −0.1 (− 0.3 to 0.05)
LDL cholesterol (mmol/L)
3 months 188 3.4 3.4 0.0 (−0.2 to 0.2)
12 months 184 3.4 3.5 −0.1 (− 0.2 to 0.1)
HDL cholesterol (mmol/L)
3 months 188 1.6 1.6 0.0 (−0.06 to 0.04)
12 months 184 1.6 1.6 0.0 (−0.1 to 0.03)
Triglycerides (mmol/L)b
3 months 188 1.4 1.5 −0.1 (− 0.25 to 0.03)
12 months 184 1.4 1.5 −0.1 (− 0.2 to 0.1)
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outcomes, including explanations related to the novel
multidimensional approach that was employed in MIPA
CT for the first time. We recruited patients based on the
presence of a specific score in a predefined physical ac-
tivity dimension (PAL <2.0), and thus participants could
still score relatively highly for other physical activity di-
mensions. To illustrate this point, the majority of partici-
pants (58%) scored highly (green) for at least one
physical activity dimension at baseline and only 11 par-
ticipants (5%) had universally low physical activity across
all dimensions (Fig. 2). Thus, most participants would
have received at least a partially positive message about
some aspect of their physical activity behaviour from the
online platform and during health trainer sessions. From
a behaviour change standpoint, receiving positive feed-
back (even in just one dimension of physical activity)
could reinforce the “appropriateness” of an individual’s
existing behaviour and lessen the perceived need to
change physical activity behaviour, especially in areas
that participants do not think match their lifestyle and
their preferences [12, 13]. Clinical practice might con-
sider focusing on priority populations with uniformly
low physical activity across all dimensions.
The lack of substantial intervention effects could also
be explained by study inclusion based on absolute risk
scores, which may be biased towards healthy older
people. Disease-risk algorithms such as QRisk do not
directly consider the impact of physical activity and esti-
mated risk is heavily influenced by age [17]. To illustrate
this point, a lean non-smoking 64-year old man with no
family history or risk factors for cardiovascular disease
would have been eligible for MIPACT with a 10-year
QRISK score of 13.9%. Thus, inclusion was heavily
influenced by age-related absolute risk score, which is a
poor proxy for lifestyle-related health outcomes. Indeed,
in MIPACT, participants had a slightly higher mean
PAL (1.68) than the UK median (1.63) [39, 40]. Thus,
Health Check programmes with a focus on prevention
may need to avoid using absolute risk scores and con-
sider targeting populations with higher relative risk.
Strengths and limitations of this study
The current study has several important strengths. We
used a precise device-based measure of physical activity
and achieved exceptional 24-h, 7-day compliance (>
98%) across all assessment periods. We adopted an in-
novative approach to try and avoid short-term changes
in physical activity during assessment periods by using
sham activity monitors in the 1-month prior to follow-
up [15]. Also, we adopted a pragmatic intention-to-treat
(as randomised) analysis as well as an extended post-
intervention follow-up assessment at 12 months. Partici-
pant retention in the trial was high (91%) and did not
differ substantially between study groups. The study also
had a number of limitations. Participants came from a
single UK region, were well educated, and exhibited lim-
ited ethnic and socioeconomic diversity. As such, our
findings may not be generalisable to other cohorts and
settings, although representativeness is not a prerequisite
for a valid evaluation of relative efficacy/ effectiveness in
a randomised trial [41].
Conclusions
In primary care patients at risk of cardiovascular disease
and/or type II diabetes, a highly sophisticated digital
monitoring system along with support from a health
Table 3 Adjusted means for health-related outcomes at 3 and 12-monthsa (Continued)
Variable N Intervention Control Difference (90% CI)
CRP (mg/l)b
3 months 186 2.5 3.3 −0.8 (− 1.5 to − 0.1)
12 months 183 3.2 3.1 0.1 (−0.7 to 0.9)
CVD risk: 10-year risk (%)b
3 months 188 14.0 14.0 0.0 (−0.5 to 0.5)
12 months 186 15.0 14.9 0.1 (−0.5 to 0.7)
Diabetes risk: 10-year risk (%)b
3 months 188 12.8 13.0 −0.2 (− 0.7 to 0.3)
12 months 186 12.9 13.6 −0.7 (−1.5 to 0.02)
EQ-5D
3months 184 77.4 74.3 3.1 (0.0 to 6.2)
12 months 186 75.7 72.4 3.3 (−1.4 to 8.2)
Abbreviations: SBP Systolic blood pressure, DBP Diastolic blood pressures, HOMA-IR Homeostatic model assessment – Insulin resistance, LDL Low density
lipoprotein, HDL High density lipoprotein, CRP C-reactive protein, CVD Cardiovascular disease, EQ. 5D Health related quality of life
a Adjusted for all minimization factors and baseline value of the outcome variable
b Confidence interval verified using a bias-corrected and accelerated bootstrap with 2000 replications
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trainer (MIPACT) did not increase mean physical activ-
ity levels compared to usual care. MIPACT shows that
physical activity is hard to change in patients recruited
from primary care in the longer term, even with highly
sophisticated digital technologies. The multidimensional
individual-level characterisation revealed enormous het-
erogeneity in physical activity in primary care patients,
and only a small proportion of patients had low physical
activity across all dimensions. Practitioners may need to
screen for inactivity across multiple outcomes/metrics
rather than rely on disease-risk algorithms that are heav-
ily influenced by age.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12966-020-00998-5.
Fig. 2 Multidimensional Physical Activity Profiles of Participants at Baseline. a Unadjusted physical activity data of participants across multiple
specific dimensions of physical activity at baseline b Proportion of participants scoring highly for one or more dimensions of physical activity at
baseline. PAL, Physical Activity Level (ratio of total daily energy expenditure to resting metabolic rate); SED, Sedentary; MVPA, moderate-to-
vigorous physical activity; MVPA10, moderate-to-vigorous physical activity in bouts of at least 10 min; VIG10, Vigorous physical activity in bouts of
at least 10 min. In this simple iteration, and as described [15], green/red indicate achievement/failure to achieve each threshold, with amber
indicating that values are near to achieving the threshold
Peacock et al. International Journal of Behavioral Nutrition and Physical Activity           (2020) 17:99 Page 11 of 13
Additional file 1. CONSORT 2010 checklist of information to include
when reporting a randomised trial*
Additional file 2. The TIDieR (Template for Intervention Description and
Replication) Checklist*
Abbreviations
MIPACT: Multidimensional Individualised Physical ACTivity; NHS: National
Health Service; PAL: Physical Activity Level; MVPA: Moderate-to-Vigorous
Physical Activity; METs: Metabolic Equivalents; MCID: Minimum Clinically
Important Difference
Acknowledgements
We thank the participants for taking part, healthcare professionals, research
nurses, National Institute for Health Research Clinical Research Network,
Primary Care Research Network, NHS Bath and North East Somerset Clinical
Commissioning Group, and NHS Wiltshire Clinical Commissioning Group. We
also thank the trial steering committee that was chaired by Professor David
Stensel (School of Sport, Exercise and Health Sciences, Loughborough
University). Professor Ashley Cooper (School for Policy Studies, University of
Bristol) and John Goodall (Associate Director, Public Health, Wilshire Council)
were also independent members of the trial steering committee.
Authors’ contributions
DT, AB, MS, AS and AT obtained funding for the research. DT, OP, AB, MW,
MS, AS and AT contributed towards the design of the study. OP led study
co-ordination and OP, MW and EC were involved in the collection and pro-
cessing of data. AB developed the statistical analysis plan and undertook the
analyses. OP, DT and AB drafted the manuscript with critical input from all
other authors. All authors have read and approved the final draft. DT is the
guarantor.
Funding
Funding for the project was provided by the National Preventative Research
Initiative (NPRI, http://www.mrc.ac.uk/research/initiatives/national-prevention-
research-initiative-npri/) under grant MR/J00040X/1. Funding partners are:
Alzheimer’s Research Trust, Alzheimer’s Society, Biotechnology and Biological
Sciences Research Council, British Heart Foundation; Cancer Research UK;
Chief Scientists Office, Scottish Government Health Directorate; Department
of Health; Diabetes UK; Economic and Social Research Council; Health and
Social Care Research and Development Division of the Public Health Agency;
Medical Research Council; The Stroke Association; Wellcome Trust; Welsh
Assembly Government; and World Cancer Research Fund. The funders had
no role in the design and conduct of the study; collection, management,
analysis, and interpretation of the data; preparation, review, or approval of
the manuscript; and decision to submit the manuscript for publication.
Availability of data and materials
All the individual participant data collected during the trial (along with the
data dictionary) will be available, after deidentification, immediately following
publication with no end date. Data will be available to anyone and for any
purpose. The study protocol has been published. Data are available
indefinitely at: https://doi.org/10.15125/BATH-00713
Ethics approval and consent to participate
Ethics approval was obtained from the National Health Service (NHS) South
West Research Ethics Committee (13/SW/0179). All patients provided written
informed consent prior to entering the study.
Consent for publication
Not applicable.
Competing interests
DT declares shareholdings in Moki Technology Ltd. All other authors declare
no competing interests.
Author details
1Department for Health, University of Bath, Bath BA2 7AY, UK. 2School of
Health and Life Sciences, Teesside University, Middlesbrough, UK. 3School of
Sport, Exercise and Rehabilitation Sciences, University of Birmingham,
Birmingham, UK. 4Bristol Business School, University of West of England,
Bristol, UK.
Received: 21 April 2020 Accepted: 21 July 2020
References
1. Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT, et al. Effect of
physical inactivity on major non-communicable diseases worldwide: an
analysis of burden of disease and life expectancy. Lancet. 2012;380(9838):
219–29.
2. Department of Health. Putting prevention first - vascular checks: risk
assessment and management. London: Department of Health Publications;
2009. p. 1–38.
3. Sanchez A, Bully P, Martinez C, Grandes G. Effectiveness of physical activity
promotion interventions in primary care: a review of reviews. Prev Med.
2015;76:S56–67.
4. Phillips SM, Cadmus-Bertram L, Rosenberg D, Buman MP, Lynch BM.
Wearable technology and physical activity in chronic disease: opportunities
and challenges. Am J Prev Med. 2018;54(1):144–50.
5. Davies CA, Spence JC, Vandelanotte C, Caperchione CM, Mummery WK.
Meta-analysis of internet-delivered interventions to increase physical activity
levels. Int J Behav Nutr Phys Act. 2012;9:52.
6. Direito A, Carraca E, Rawstorn J, Whittaker R, Maddison R. mHealth
technologies to influence physical activity and sedentary behaviors:
behavior change techniques, systematic review and meta-analysis of
randomized controlled trials. Ann Behav Med. 2017;51(2):226–39.
7. Michie S, Abraham C, Whittington C, McAteer J, Gupta S. Effective
techniques in healthy eating and physical activity interventions: a meta-
regression. Health Psychol. 2009;28(6):690–701.
8. Greaves CJ, Sheppard KE, Abraham C, Hardeman W, Roden M, Evans PH,
et al. Systematic review of reviews of intervention components associated
with increased effectiveness in dietary and physical activity interventions.
BMC Public Health. 2011;11:1–2.
9. O'Brien N, McDonald S, Araujo-Soares V, Lara J, Errington L, Godfrey A, et al.
The features of interventions associated with long-term effectiveness of
physical activity interventions in adults aged 55-70 years: a systematic
review and meta-analysis. Health Psychol Rev. 2015;9(4):417–33.
10. Thompson D, Peacock O, Western M, Batterham AM. Multidimensional
physical activity: an opportunity, not a problem. Exerc Sport Sci Rev. 2015;
43(2):67–74.
11. 2018 PAGAC. Physical activity guidelines committee scientific report.
Washington, DC: US Department of Health and Human Services; 2018.
12. Western MJ, Peacock OJ, Stathi A, Thompson D. The understanding and
interpretation of innovative technology-enabled multidimensional physical
activity feedback in patients at risk of future chronic disease. PLoS One.
2015. https://doi.org/10.1371/journal.pone.0126156.
13. Western MJ, Thompson D, Peacock OJ, Stathi A. The impact of
multidimensional physical activity feedback on healthcare practitioners and
patients. BJGP Open. 2019. https://doi.org/10.3399/bjgpopen18X101628.
14. Thompson D, Batterham AM. Towards integrated physical activity profiling.
PLoS One. 2013;8(2):e56427.
15. Peacock OJ, Western MJ, Batterham AM, Stathi A, Standage M, Tapp A, et al.
Multidimensional individualised physical ACTivity (mi-PACT) - a technology-
enabled intervention to promote physical activity in primary care: study
protocol for a randomised controlled trial. Trials. 2015;16:381.
16. Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P. Predicting risk of
type 2 diabetes in England and Wales: prospective derivation and validation
of QDScore. Br Med J. 2009;338:15.
17. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A,
et al. Predicting cardiovascular risk in England and Wales: prospective
derivation and validation of QRISK2. Br Med J. 2008;336(7659):1475.
18. Dumville JC, Hahn S, Miles JNV, Torgerson DJ. The use of unequal
randomisation ratios in clinical trials: a review. Contemp Clin Trials. 2006;
27(1):1–12.
19. Treasure T, MacRae KD. Minimisation: the platinum standard for trials?
Randomisation doesn’t guarantee similarity of groups; minimisation does. Br
Med J. 1998;317(7155):362–3.
20. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M.
Developing and evaluating complex interventions: the new Medical
Research Council guidance. Br Med J. 2008;337(7676):5.
Peacock et al. International Journal of Behavioral Nutrition and Physical Activity           (2020) 17:99 Page 12 of 13
21. van Middelaar T, Beishuizen CRL, Guillemont J, Barbera M, Richard E, Moll
van Charante EP, et al. Engaging older people in an internet platform for
cardiovascular risk self-management: a qualitative study among Dutch HATI
CE participants. BMJ Open. 2018;8(1):e019683.
22. Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman
W, et al. The behavior change technique taxonomy (v1) of 93
hierarchically clustered techniques: building an international consensus
for the reporting of behavior change interventions. Ann Behav Med.
2013;46(1):81–95.
23. Gillison FB, Rouse P, Standage M, Sebire SJ, Ryan RM. A meta-analysis
of techniques to promote motivation for health behaviour change from
a self-determination theory perspective. Health Psychol Rev. 2019;13(1):
110–30.
24. Samdal GB, Eide GE, Barth T, Williams G, Meland E. Effective behaviour
change techniques for physical activity and healthy eating in overweight
and obese adults; systematic review and meta-regression analyses. Int J
Behav Nutr Phys Act. 2017;14(1):42.
25. Ryan RM, Deci EL. Self-determination theory and the facilitation of
intrinsic motivation, social development, and well-being. Am Psychol.
2000;55(1):68–78.
26. Ryan RM, Patrick H, Deci EL, Williams GC. Facilitating health behaviour
change and its maintenance: interventions based on self-determination
theory. Eur Health Psychol. 2008;10(1):2–5.
27. Standage M, Ryan RM. Self-determination theory and exercise motivation:
facilitating self-regulatory processes to support and maintain health and
well-being. In: Roberts GC, Treasure DC, editors. Advances in motivation in
sport and exercise. Champaign: Human Kinetics; 2012. p. 233–70.
28. Bellg AJ, Borrelli B, Resnick B, Hecht J, Minicucci DS, Ory M, et al. Enhancing
treatment fidelity in health behavior change studies: best practices and
recommendations from the NIH behavior change consortium. Health
Psychol. 2004;23(5):443–51.
29. Schofield WN. Predicting basal metabolic rate, new standards and review of
previous work. Clin Nutr. 1985;39(Suppl 1):5–41.
30. Johannsen DL, Calabro MA, Stewart J, Franke W, Rood JC, Welk GJ. Accuracy
of armband monitors for measuring daily energy expenditure in healthy
adults. Med Sci Sports Exerc. 2010;42(11):2134–40.
31. Jakicic JM, Davis KK, Rogers RJ, King WC, Marcus MD, Helsel D, et al. Effect
of wearable technology combined with a lifestyle intervention on long-
term weight loss: the IDEA randomized clinical trial. JAMA. 2016;316(11):
1161–71.
32. EuroQol. A standardised instrument for use as a measure of health
outcome. 1996; http://www.euroqol.org/.
33. Frison L, Pocock SJ. Repeated measures in clinical trials - analysis using
mean summary statistics and its implications for design. Stat Med. 1992;
11(13):1685–704.
34. Rothman KJ. No adjustments are needed for multiple comparisons.
Epidemiology. 1990;1(1):43–6.
35. Bakrania K, Edwardson CL, Khunti K, Henson J, Stamatakis E, Hamer M, et al.
Associations of objectively measured moderate-to-vigorous-intensity
physical activity and sedentary time with all-cause mortality in a population
of adults at high risk of type 2 diabetes mellitus. Prev Med Rep. 2017;5:285–
8.
36. Amrhein V, Trafinnow D, Greenland S. Inferential statistics as descriptive
statistics: there is no replication crisis if we don’t expect replication. Am Stat.
2019;73:262–70.
37. van der Weegen S, Verwey R, Spreeuwenberg M, Tange H, van der Weijden
T, de Witte L. It’s LiFe! Mobile and web-based monitoring and feedback tool
embedded in primary care increases physical activity: a cluster randomized
controlled trial. J Med Internet Res. 2015. https://doi.org/10.2196/jmir.4579.
38. Harris T, Kerry SM, Limb ES, Victor CR, Iliffe S, Ussher M, et al. Effect of a
primary care walking intervention with and without nurse support on
physical activity levels in 45-to 75-year-olds: the pedometer and
consultation evaluation (PACE-UP) cluster randomised clinical trial. PLoS
Med. 2017. https://doi.org/10.1371/journal.pmed.1002210.
39. Scientific Advisory Committee for Nutrition. Dietary reference values for
energy. London: The Stationery Office; 2011.
40. Thompson D, Batterham AM, Peacock OJ, Western MJ, Booso R. Feedback
from physical activity monitors is not compatible with current
recommendations: a recalibration study. Prev Med. 2016;91:389–94.
41. Senn SJ. Falsificationism and clinical trials. Stat Med. 1991;10(11):1679–92.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Peacock et al. International Journal of Behavioral Nutrition and Physical Activity           (2020) 17:99 Page 13 of 13
